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F-Fluoride and 18 F-FDG PET After TIA/Ischemic Stroke decision-making. Such biomarkers could also assess the response of plaque biology to novel pharmacological interventions and provide a way of identifying culprit lesions in patients with multiple plaques. Hybrid positron emission tomography and computed tomography (PET/CT) is a molecular imaging modality that has high sensitivity for noninvasive in vivo detection of radiolabeled biomolecules tuned to a variety of pathophysiological processes. In carotid atherosclerosis imaging, the most widely used tracer has been 18 F-fluorodeoxyglucose ( 18 F-FDG) [8] [9] [10] [11] [12] [13] [14] : Recently, we have described another radiotracer, 18 F-fluoride, in atherosclerosis imaging. 15, 16 We [15] [16] [17] [18] and others [19] [20] [21] [22] [23] have shown that this tracer has major potential in cardiovascular disease. 18 F-Fluoride can highlight culprit plaque in patients after myocardial infarction and high-risk plaques in patients with apparently stable coronary heart disease. 16 We have shown that this is because 18 F-fluoride can highlight areas of microcalcification indicative of necrotic atheroma. 24 The ability to identify high risk or culprit plaque in the cephalic circulation has the potential to improve risk stratification in patients at high risk of stroke with a view to more targeted interventions. Our study aims were to compare and contrast the identification of clinically adjudicated culprit and highrisk plaque at the carotid bifurcation using 18 F-fluoride and 18 F-FDG PET/CT.
Methods

Patient Population
Two cohorts of people with a recent transient ischemic attack (TIA) or minor ischemic stroke were recruited: a case cohort with a high-grade internal carotid artery stenosis (≥50% by North American Symptomatic Carotid Endarterectomy Trial 25 criteria for men, ≥70% for women) scheduled to undergo carotid endarterectomy and a control cohort in whom the cause of stroke was not attributed to carotid atheroma. Participants were recruited from outpatient clinics in National Health Service Lothian between January 2013 and June 2014 (for exclusion criteria, see Appendix in the Data Supplement). Research ethics committee approval (National Health Service West of Scotland Research Ethics Committee: 12/WS/0227) and the written and informed consent of all participants were obtained.
Baseline Assessment
Participants underwent clinical assessment at baseline including standard hematologic and biochemical indices. Serum C-reactive protein concentration was measured using the MULTIGENT CRP Vario assay on the high-throughput ARCHITECT system (Abbott Laboratories, Abbott Park, IL). Predicted cardiovascular risk was estimated using the ASSIGN score: a validated Scottish cardiovascular risk score that is similar to the Framingham risk score but includes additional factors, such as social deprivation and family history.
26
PET/CT Protocol
Static
18 F-FDG PET/CT was acquired using a hybrid scanner (Biograph mCT, Siemens Medical Systems, Erlangen, Germany) 90 minutes after the intravenous administration of a target dose of 200 MBq. A rigid neck collar was fitted to minimize movement and standardize position. An attenuation-correction CT scan (nonenhanced, low dose 120 kV, 50 mAs) was then performed followed by PET acquisition covering 2 bed positions with the first upper bed centered over the carotid bifurcation in 3-dimensional mode for 20 minutes per bed. Patients were fasted for 6 hours before scanning. 18 F-Fluoride PET/CT was undertaken the subsequent day 60 minutes after administering 250 MBq 18 F-fluoride. A neck collar was 18 F-fluoride PET/CT with pharmacokinetic analysis as described previously. 24 Dynamic PET provides a quantitative assessment of uptake and these data were used to validate the semiquantitative static imaging data.
After PET acquisition, a CT carotid angiogram was performed without moving the subject (Care Dose 4D, 120 kV, 145 mA, rotation time 0.5 seconds, pitch 0.8. Contrast: 50 mL Niopam 370).
Static PET data were reconstructed using the Siemens UltraHD algorithm: ordered subset expectation maximization+point spread function modeling+time-of-flight; 2 iterations and 21 subsets; matrix size 200×200; 5 mm full-width half-maximum Gaussian smoothing. Dynamic PET data were similarly reconstructed but only using coincident events from the 60-to 75-minute time-bin. Dynamic data were analyzed as reported previously 24 and a K i value was calculated using Patlak analysis. 27, 28 Tissue Collection, Micro PET/CT, and Histology
At the time of endarterectomy, plaques were collected immediately after excision, photographed, and snap frozen. A random selection (n=8) of specimens was analyzed by micro PET/CT and histology to explore 
Image Analysis
Positron Emission Tomography/Computed Tomography
Static analysis of 18 F-FDG and 18 F-fluoride uptake was performed on an OsiriX workstation (OsiriX version 3.5.1 64-bit; OsiriX Imaging Software, Geneva, Switzerland). PET/CT data were reviewed alongside the CT angiogram. Scans were qualitatively assessed for registration, image quality, patient movement, and visual evidence of radiotracer uptake. PET and CT data were individually and carefully manually coregistered by lining up fiducial markers apparent on both modalities (eg, cervical spine, mandible and hyoid on 18 F-fluoride imaging; skin, spinal cord, and brain on 18 F-FDG imaging). No formal inter-PET registration was performed. Three regions of interests (ROIs) were drawn on the carotid of interest on adjacent 3-mm axial slices. If a plaque was present, the ROIs were centered on the area of highest uptake. If there was no plaque, the uptake in the proximal 1 cm of internal carotid artery, just distal to the bifurcation was quantified. From these, standardized uptake values (SUVs; maximum, mean maximum, and mean) were recorded. Blood pool activity was determined from the average of 5 ROIs within the lumen of the superior vena cava to calculate target to background ratios.
Uptake in the proximal left common carotid artery was quantified to explore the relationships between arterial 18 F-FDG and 18 F-fluoride uptake in a site unaffected by an acute plaque event. Three ROIs were placed around this vessel and uptake was recorded.
Inter-and intraobserver reproducibility of 18 F-fluoride uptake measurements were determined using a random selection of 12 patients (24 carotids) by 2 experienced observers (A.T.V., G.S.) who were blinded to the clinical data during analysis.
Computed Tomography
The CT angiogram was assessed for image quality, plaque presence, location, and characteristics. Analysis was undertaken on a cardiovascular workstation (Vital Images, Minnetonka, MN). A blinded and experienced observer (A.V.) performed the semiautomated CT plaque analysis.
Statistical Analysis
Radiotracer uptake, expressed as mean and maximum SUV, was compared between the clinically adjudicated culprit carotid plaque and the contralateral side. Continuous variables are expressed as mean±standard deviation for normally distributed data and median (interquartile range) for skewed distributions. Skewed datasets underwent logarithmic transformation to normalize their distribution. Parametric (unpaired and paired t-tests) and nonparametric (MannWhitney U or Wilcoxon matched-pairs signed rank) tests were used for normally distributed and skewed data, respectively. Categorical 
F-Fluoride and
18 F-FDG PET After TIA/Ischemic Stroke data are presented as n (%) and were compared using Fisher's exact or Chi-squared tests. Correlation was undertaken with either Pearson's r or Spearman's ρ subject to the normality of the variables tested.
To quantify inter-and intraobserver reproducibility of 18 F-fluoride uptake measurement, the intraclass correlation coefficient was calculated and Bland-Altman analysis was undertaken.
Statistical analyses were performed with the use of SPSS version 18 (SPSS Inc, Chicago, IL) and Graph Pad Prism version 6.0 (GraphPad Software Inc, San Diego, CA). Statistical significance was defined as a 2-sided P<0.05.
Results
Study Population
We recruited 26 patients: 18 in the carotid endarterectomy cohort and 8 in the control cohort ( Figure I in the Data Supplement). Baseline characteristics (Table 1) were similar in both cohorts. Twenty patients completed all the imaging techniques ( Figure 1) . A minority did not receive all scans because of the technical and feasibility challenges of completing our multimodality imaging protocol in the very short time frame before surgery. Actual doses and uptake times are specified in Table I in the Data Supplement. There were no adverse events during the study. There were 3 withdrawals.
Micro PET/CT and Histology
18 F-Fluoride was observed to selectively highlight areas of pathologically high-risk microcalcification (Figure 2 and Supplementary Movie I in the Data Supplement). Both on autoradiography and micro PET/CT, 18 F-fluoride was observed to bind avidly to areas of microcalcification but only to the surface of large volume stable macrocalcifications. Our previous studies 24 would suggest that this was because of the inability of the fluoride ion to penetrate to the deeper layers of a large crystalline mass (with a low surface-area-to-volume ratio). In contradistinction, the powdery deposits of microcalcification (not visible on CT) provide a large area (high surface-area-tovolume ratio) for the fluoride ion to bind.
Imaging
When comparing the 18 F-fluoride uptake on static imaging with full dynamic modeling, K i was most strongly correlated with the SUV mean (r=0.93 [95% confidence interval 0.64-0.99], P=0.001; Figure 3 ). There were no fixed or proportional biases in the SUV measurements within and between observers (Table II in the Data Supplement). These assessments also demonstrated high intraclass correlation coefficients (all >0.90).
Assessment of Uptake: Culprit Compared With Contralateral and Controls
18 F-Fluoride uptake was variably present in most plaques with all culprits showing uptake on visual assessment. In the large majority of patients undergoing carotid endarterectomy who were scanned (87%; 13/15), there was more visual uptake of 18 F-fluoride in the culprit compared with the contralateral A, C, F) . These examples show that 18 F-fluoride provides information of the presence of microcalcification and does not simply highlight all calcification. E, An example of micro CT slice registered to an alizarin red-stained section and the corresponding autoradiogram from a specimen that had been incubated whole in 18 F-fluoride. It can be seen that the tracer is unable to penetrate the deeper layers of macrocalcification (black arrow), but is able to highlight microcalcification beyond the resolution of even micro CT (red arrow), thus explaining the findings in the micro PET/CT images.
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18 F-FDG PET After TIA/Ischemic Stroke side. In the 2 patients without discriminatory uptake, there was heavy uptake bilaterally but more 18 F-fluoride uptake on the contralateral side. One patient had grossly ossified carotids and the second, at the time of surgery, was found to have a fibrous stenosis (low signal side) and was subsequently admitted with a fatal ischemic stroke on the contralateral side (high signal side, Figure 3J) . 18 F-Fluoride uptake was focal and readily identifiable with excellent signal to background discrimination. Spillover from the hyoid bone, thyroid cartilage and cervical vertebrae occasionally made drawing ROI difficult, but only 1 vessel was rendered uninterpretable. On SUV analysis, the clinically adjudicated culprit showed higher uptake than either the paired contralateral (log 10 SU-V mean 0.29±0.10 versus 0.23±0.11, P=0.001) or an unpaired control (log 10 SUV mean 0.29±0.10 versus 0.12±0.11, P=0.001) irrespective of the method of quantification (Table 2 and Figures 3 and 4) .
Of note, in patients with a stroke in whom the imaging extended to encompass the affected territory of the brain (n=3), intense 18 F-fluoride uptake was noted in regions of cerebral infarction (SUV mean 4.8±1.98 versus SUV mean of 0.07±0.02 for contralateral noninfarcted brain, P<0.001; Figure 3B and 3C, Movie II in the Data Supplement).
Seven of the 16 culprit carotid plaques demonstrated clear and discernible increased 18 F-FDG uptake. However, this uptake was generally more diffuse than 18 F-fluoride and analysis was more frequently hampered by overspill from sternocleidomastoid, longus colli, tonsillar tissue, and the submandibular salivary glands (Figure 1 ). This rendered 5 vessels noninterpretable. In the remaining 4 culprit vessels, no increase in 18 Figure 4 ).
Uptake Compared With Plaque Features and Baseline Characteristics
18 F-Fluoride uptake was correlated with several plaque characteristics on CT plaque analysis ( Table 3 ). The strongest 
Discussion
We have shown that the culprit plaques of patients with recent TIA or minor ischemic strokes enhance with 18 F-fluoride on PET/CT. Uptake was focal, readily identifiable, and discriminated between culprit and nonculprit. 18 F-Fluoride uptake was associated with high-risk plaque phenotype and predicted cardiovascular risk. In contrast, while 18 F-FDG uptake was present in plaque and correlated with cardiovascular risk, it was more diffuse and prone to spillover and therefore less discriminatory. 18 F-FDG also failed to correlate with established high-risk plaque morphological features.
We have previously shown that 18 F-fluoride uptake is associated with increased intraplaque markers of cell death, procalcific proteins, inflammation, and high-risk features in the coronary circulation in vivo and the carotid system ex vivo. 16 Here, we confirm our previous observations 24 (which we have also recently reviewed 29 ) that this is explained by the ability of 18 F-fluoride to report microcalcification. Why is this the case? Far from a passive and degenerative process, vessel mineralization is a controlled response to a variety of insults, particularly oxidized inflammatory lipid (as in the calcific response to tuberculosis infection where lipid-rich bacterial cell walls become oxidized through leukocyte action). It is therefore perhaps no surprise that direct links between atherosclerosis and the induction of extraskeletal osteogenesis have been identified. 30, 31 The presence of cellular necrosis and apoptosis 32 is also likely to potentiate this relationship further. Hydroxyapatite nanocrystals themselves may also further drive the inflammatory cycle by setting up a positive feedback loop of increasing calcification, increasing inflammation, and increasing cell death. 30 Furthermore, by accumulating in the surface of thin fibrous caps, microcalcifications may focally increase mechanical stress and thus promote structural cap failure and plaque rupture.
7,33,34 18 F-Fluoride can demonstrate this pathologically important microscopic calcific response. Parametric data presented as mean±SD. Nonparametric data presented as median (IQR). FDG indicates fluorodeoxyglucose; SUV, standardized uptake value; TBR, target to background ratio; and IQR, interquartile range.
*Statistical testing performed on the normalized log 10 transformed data. 
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This is the first observation of 18 F-fluoride uptake in necrotic brain tissue and merits consideration. Uptake of this and other bone metabolism markers has previously been observed in tissue necrosis. 33, 35 This is likely to be because of cell membrane disruption with influx of calcium and formation of nanoscale calcium phosphate complexes. These offer a substrate to which 18 F-fluoride can adsorb, allowing us to visualize the microcalcification associated with necrosis. We have also observed the same process in myocardial tissue postinfarction ( Figure II in the Data Supplement).
We confirmed identification of culprit plaque in 2 ways. First, we compared the culprit to the ideal internal control, the contralateral carotid artery (which is almost invariably diseased). Second, we compared the culprit against a valid external control; patients with a TIA or minor ischemic stroke not attributed to carotid plaque. This shows that 18 F-fluoride may have real potential in helping to identify culprit plaque thus helping decision-making. This is exemplified by the case where a plaque with high uptake deemed nonculprit subsequently caused a fatal ischemic stroke.
We compared uptake of F-FDG alone in carotid atherosclerosis [9] [10] [11] 14, [36] [37] [38] [39] and a few have directly compared clinical culprit with nonculprit plaques. 8, 12, 13 Our results are consistent with these previous findings with significant uptake noted in some but not all culprit plaques, in part because of spillover from adjacent muscle. Our observations are also influenced by the ubiquity of statin therapy, potentially blunting 18 F-FDG uptake. We did, however, note that proximal carotid uptake correlated with cardiovascular risk indicating that 18 F-FDG does reflect a major aspect of vessel pathobiology. As others suggest, 38, 40 it may be that 18 F-FDG better reflects generalized vascular inflammation and that the relationship between the tracer and a single advanced and acute plaque is more complicated. There are increasing data available concerning other more specific markers of inflammation, such as those targeting the macrophage-specific somatostatin receptor. 41 These will theoretically be less hampered by overspill. Our findings confirm those of a smaller study of 9 patients by Quirce et al 23 that explored 18 F-fluoride and 18 F-FDG uptake in symptomatic patients. They showed that 18 F-fluoride uptake appeared to be higher in the symptomatic carotid and that 18-FDG uptake was nondiscriminatory. Taken together with our current larger series, this suggests that 18 F-fluoride has the potential to be a useful and robust clinical tool to identify culprit atherosclerotic plaque. Vascular 18 F-fluoride imaging could therefore guide clinical management better than the current standard of care, and lead to trials of plaque-specific interventions that go beyond simple assessments of anatomic luminal stenosis severity.
Limitations
This was a small pilot observational study (recruitment is very challenging given the time pressure to intervene) and findings should be regarded as preliminary. The true utility of 18 F-fluoride PET/CT will need to be evaluated by prospective studies with patients randomized to intervention based on imaging.
18 F-Fluoride PET/CT will need to be 43 We also acknowledge that quantitative vascular PET has some potential limitations because of the partial volume effects of small vascular structures. Finally, as vascular 18 F-fluoride imaging is developed, consideration must be given to harmonizing acquisition and reconstruction protocols, 44 as well as achieving consensus on the uptake parameter of choice (SUV versus target to background ratio versus volumetric parameters 45 ) and whether to use manual or automated methods to define ROI. This will reduce variation between scanners and research groups and permit meaningful multicenter studies.
Conclusion
We have shown that 18 F-fluoride PET/CT is able to identify culprit or high-risk carotid plaque. In comparison, 18 F-FDG, the most widely used tracer in cardiovascular PET imaging, did not reliably identify culprit plaque and did not correlate with high-risk morphological features. 18 F-Fluoride PET has major potential to improve how we assess and manage the risk of stroke in patients with atherosclerosis.
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